At a Glance – Zika in the U.S. (updated 4/12/17*)
Travel-associated Zika virus disease cases reported: 4,935
Locally acquired vector-borne cases reported: 223
Laboratory acquired cases reported: 1
Pregnant Women with Any Lab Evidence of Zika Virus Infection: 1,716
Liveborn infants with birth defects: 56
Pregnancy losses with birth defects: 7
Of the 5,234 cases reported, 46 were sexually transmitted.
Total cases reported: 36,526
Travel-associated cases reported: 143
Locally acquired cases reported: 36,383
Pregnant Women with Any Lab Evidence of Zika Virus Infection: 3,461
*Visit CDC.gov for the most up to date information.
New from ASTHO: Top Questions on Zika: Simple Answers
Zika virus is a mosquito-borne flavivirus transmitted to humans primarily by the Aedes aegypti mosquitoes, the same mosquitoes that transmit dengue, yellow fever, and chikungunya viruses. CDC estimates that 80 percent of Zika cases are asymptomatic. Symptomatic cases usually result in mild illness and symptoms such as acute onset of fever, rash, joint pain, and conjunctivitis. Some evidence suggests severe outcomes such as Guillian-Barre syndrome and microcephaly in infants via maternal-fetal transmission of Zika virus. There is currently no vaccine to prevent or medicine to treat Zika virus. For more information on Zika virus in the United States see CDC's Zika Virus web page: www.cdc.gov/Zika.
ASTHO staff have compiled the following links to selected resources and background materials that were created by state and territorial health departments and national and international sources for use by state health agency leaders. We'll add to these materials periodically.
On Monday, April 10, ASTHO hosted a Desk Side Media Conference Call: “State and Territorial Health Response to Zika – How Agencies are Preparing for Spring 2017” with featured remarks provided by ASTHO President Jay Butler (AK); ASTHO President-elect Brenda Fitzgerald (GA); Nate Smith (AR), Chair of the ASTHO Zika Task Force; Peggy Honein, Co-lead of CDC’s Zika Pregnancy and Birth Defects Task Force; and ASTHO Executive Director Mike Fraser. Approximately 10 national media correspondents attended. In addition to an article that appeared in CQ/Roll Call, “State Health Leaders Call for Sustained Anti-Zika Funding”, the following articles were written to date:
Washington Examiner: Fearing Zika, states ready for mosquito season
Homeland Preparedness News: Public health group calls for increased resources to combat the spread of Zika virus
Additionally, ASTHO staff met with representatives from CDC’s Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases; and Birth Defects Branch, National Center on Birth Defects and Developmental Disabilities to discuss Zika preparedness and response sustainment activities and ongoing coordination and collaboration opportunities as we prepare for the upcoming mosquito season.
Zika Pregnancy and Birth Defects Local Health Department Field Support Funding Opportunity
CDC is soliciting applications for a second round of placements for the Zika Pregnancy and Birth Defects Field Support program. CDC’s Zika supplemental funding for pregnancy and birth defects supports field assignees in 16 city, county, and territorial health departments. The application process is open April 10-April 21, with site visits to the selected jurisdictions occurring from May 3-May 26.
CDC and AAP: Zika Psychosocial Support Videos
Through a cooperative agreement with the Centers for Disease Control and Prevention, the American Academy of Pediatrics developed a psychosocial support video for clinicians and two videos for parents (in English and Spanish). These videos provide guidance for providers and parents specific to the psychosocial support that will be needed when facing a child born with congenital Zika virus syndrome. For more information, see the AAP News article or email DisasterReady@aap.org.
New Jersey: NJDOH and NJ American Academy of Pediatrics Co-Sponsors Conference "From ALD to Zika: Newborn Screening and Surveillance in New Jersey"
Date: April 25, 2017
Time: 8:30 a.m. – 3:30 p.m.
Location: National Conference Center, 399 Monmouth Street, East Windsor, NJ
Registration Fee: $25
July 17-19 | Summer Workshop on Pandemics, Bioterrorism, and Global Health Security: From Anthrax to Zika
Pandemics, Bioterrorism and Global Health Security: From Anthrax to Zika is a three-day, non-credit summer workshop designed to introduce participants to the challenges facing the world at the intersection of national security, public health and the life sciences. The workshop is hosted by the Schar School of Policy and Government at George Mason University. The workshop will be held July 17-19, 2017 in Arlington, VA.
This information page was developed by ASTHO to help state and territorial health officials and state health agencies stay abreast of a developing public health concern in the form of background information, pertinent materials, and ongoing updates. ASTHO staff will continue to monitor this situation. Health agencies may contact firstname.lastname@example.org with questions regarding this topic.